Can the cost of atrial fibrillation be reduced?

Can the cost of atrial fibrillation be reduced?

Bibliographic Details
Main Author:	João de Sousa
Format:	Article
Language:	English
Published:	Elsevier 2015-01-01
Series:	Revista Portuguesa de Cardiologia (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2174204915000069

Similar Items

Reduced left atrial strain can predict stroke in atrial fibrillation – A meta-analysis
by: Sonali Sachdeva, et al.
Published: (2021-10-01)

Burden of disease and cost of illness of atrial fibrillation in Portugal
by: Miguel Gouveia, et al.
Published: (2015-01-01)

Resynchronization therapy in patients with atrial fibrillation: What are the results?
by: João de Sousa
Published: (2017-10-01)

Can dexmedetomidine reduce atrial fibrillation after cardiac surgery? A systematic review and meta-analysis
by: Zhu ZP, et al.
Published: (2018-03-01)

Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for atrial fibrillation in PortugalCost-effectiveness of new oral anticoagulants in Portuguese atrial fibrillation patients
by: João Costa, et al.
Published: (2015-12-01)

Costs and clinical consequences of suboptimal atrial fibrillation management
by: Singh SN
Published: (2012-03-01)

The Antimalarial Chloroquine Reduces the Burden of Persistent Atrial Fibrillation
by: Catalina Tobón, et al.
Published: (2019-11-01)

Postoperative atrial fibrillation in paraesophageal hernia repair: can it be prevented?
by: Jennifer Mardini, et al.
Published: (2021-07-01)

CAN CLOPIDOGREL FULLY SUBSTITUTE WARFARIN AND DABIGATRAN IN ATRIAL FIBRILLATION?
by: A. B. Sumarokov
Published: (2013-08-01)

Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting
by: João Morais, et al.
Published: (2014-09-01)

Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting
by: João Morais, et al.
Published: (2014-09-01)

Statins Therapy Can Reduce the Risk of Atrial Fibrillation in Patients with Acute Coronary Syndrome: A Meta-Analysis
by: Xue Zhou, Jian-lin Du, Jia Yuan, Yun-qing Chen
Published: (2013-01-01)

Reply to the comment on “Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting”
by: João Morais
Published: (2015-11-01)

Atrial Fibrillation
by: Natig Gassanov, et al.
Published: (2013-01-01)

Atrial Fibrillation and Atrial Fibrillation Intervals—Frequency Analysis and Interpretation—
by: Akihiko Shimizu, MD, PhD, FACC
Published: (2005-01-01)

Cost-Effectiveness of Catheter Ablation for Rhythm Control of Atrial Fibrillation
by: Gord Blackhouse, et al.
Published: (2013-01-01)

Comorbidity in elderly patients with atrial fibrillation affects the “cost of illness”
by: S. V. Malchikova, et al.
Published: (2019-10-01)

Colchicine to Reduce Atrial Fibrillation in the Postoperative Period of Myocardial Revascularization
by: Camila Stuchi Zarpelon, et al.
Published: (2016-01-01)

Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients
by: Hang Zhang, et al.
Published: (2016-01-01)

Atrial Cardiomyopathy and Atrial Fibrillation in Cancer
by: Mengdi Ren, et al.
Published: (2021-01-01)

The Role of Atrial Remodelling in Atrial Fibrillation
by: Ignatius Yansen, et al.
Published: (2013-06-01)

Atrial Myopathy Underlying Atrial Fibrillation
by: Harold Rivner, et al.
Published: (2020-08-01)

Atrial fibrosis in atrial fibrillation pre-ablation assessed by CMR: impact in atrial size and function?
by: Lopes Mario G, et al.
Published: (2011-02-01)

Systematic review of cost-effectiveness analyses of novel oral anticoagulants for stroke prevention in atrial fibrillation
by: João Ferreira, et al.
Published: (2015-03-01)

Atrial Fibrillation Mechanisms and Treatment
Published: (2013)

In-hospital direct costs for thromboembolism and bleeding in Chinese patients with atrial fibrillation
by: San-Shuai Chang, et al.
Published: (2018-06-01)

Cost of illness of atrial fibrillation: a nationwide study of societal impact
by: Søren Paaske Johnsen, et al.
Published: (2017-11-01)

Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria
by: Yazid Aoudia, et al.

Cost-effectiveness of apixaban compared with warfarin for stroke prevention in atrial fibrillation.
by: Soyon Lee, et al.
Published: (2012-01-01)

Cost considerations in the management of atrial fibrillation &ndash; impact of dronedarone
by: Khaykin Y, et al.
Published: (2012-03-01)

Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
by: Mengran Zhang, et al.
Published: (2021-08-01)

ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2016-01-01)

Identification of Transient Noise to Reduce False Detections in Screening for Atrial Fibrillation
by: Hesam Halvaei, et al.
Published: (2021-06-01)

Atrial Fibrillation and Cancer
by: Ludhmila Abrahao Hajjar, et al.
Published: (2021-07-01)

Screening for atrial fibrillation
by: Zhenisgul Tlegenova, et al.
Published: (2018-03-01)

Atrial fibrillation ablation
by: Giuseppe Sgarito
Published: (2018-09-01)

Update on atrial fibrillation
by: Mohammad Shenasa, et al.
Published: (2014-09-01)

Postoperative atrial fibrillation
by: Yepanchintseva О.А.
Published: (2014-06-01)

Rivaroxaban in atrial fibrillation
by: Giorgi MA, et al.
Published: (2012-08-01)

Atrial Fibrillation and Hyperthyroidism
by: Jayaprasad N, et al.
Published: (2005-10-01)

Cannot write session to /tmp/vufind_sessions/sess_b3b1bt087ain3vhvm8ass41a5h